Coagulant Therapeutics

    OverviewSuggest Edit

    Coagulant Therapeutics ( ㈜코애귤런트테라퓨틱스는 중증산후출혈) is a biotechnology company seeking to address acute bleeding. It develops a proprietary rFVIIa molecule, termed CT-001, for the safe pharmaceutical intervention for the treatment of acute bleeding.
    TypePrivate
    Founded2017
    HQSan Francisco, CA, US
    Websitecoagulanttherapeutics.com

    Locations

    Coagulant Therapeutics is headquartered in
    San Francisco, United States

    Location Map

    Latest Updates

    Cybersecurity ratingAMore

    Coagulant Therapeutics Office Locations

    Coagulant Therapeutics has an office in San Francisco
    San Francisco, CA, US (HQ)
    455 Mission Bay Boulevard South, San Francisco
    Show all (1)

    Coagulant Therapeutics Financials and Metrics

    Summary Metrics

    Founding Date

    2017

    Coagulant Therapeutics Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    91/100

    SecurityScorecard logo

    Coagulant Therapeutics Online and Social Media Presence

    Embed Graph

    Coagulant Therapeutics Frequently Asked Questions

    • When was Coagulant Therapeutics founded?

      Coagulant Therapeutics was founded in 2017.

    • Who are Coagulant Therapeutics competitors?

      Competitors of Coagulant Therapeutics include L2P Research, Paras Biopharmaceuticals and Planet Biotechnology.

    • Where is Coagulant Therapeutics headquarters?

      Coagulant Therapeutics headquarters is located at 455 Mission Bay Boulevard South, San Francisco, San Francisco.

    • Where are Coagulant Therapeutics offices?

      Coagulant Therapeutics has an office in San Francisco.

    • How many offices does Coagulant Therapeutics have?

      Coagulant Therapeutics has 1 office.